Eton Pharmaceuticals Inc. (NASDAQ: ETON) Stock Information | RedChip

Eton Pharmaceuticals Inc. (NASDAQ: ETON)


$12.5400
+0.0400 ( +0.40% ) 26.8K

Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.

Market Data


Open


$12.5400

Previous close


$12.5000

Volume


26.8K

Market cap


$327.73M

Day range


$11.3850 - $12.7310

52 week range


$3.0300 - $13.9800

SEC Filings


Form Type Description Pages Date
8-k 8K-related 15 Dec 20, 2024
8-k 8K-related 15 Dec 17, 2024
8-k 8K-related 15 Dec 12, 2024
3 Insider transactions 2 Dec 09, 2024
8-k 8K-related 15 Dec 03, 2024
8-k 8K-related 15 Nov 25, 2024
10-q Quarterly Reports 62 Nov 12, 2024
8-k 8K-related 15 Nov 12, 2024
8-k 8K-related 15 Nov 07, 2024
4 Insider transactions 1 Oct 25, 2024

Latest News